6 names are moving together; 100% are participating in the current session.
Observed intraday paths are not available for this group yet.
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | Healthcare | +5.8% | Group member |
| BRBR | BellRing Brands, Inc. | Consumer Defensive | -0.2% | Group member |
| VRDN | Viridian Therapeutics, Inc. | Healthcare | -0.2% | Group member |
| CYTK | Cytokinetics, Incorporated | Healthcare | +0.9% | Group member |
| OSIS | OSI Systems, Inc. | Technology | +3.5% | Group member |
| FMS | Fresenius Medical Care AG | Healthcare | -0.4% | Most structurally connected |
Cohort
6 namesParticipation
100% this sessionObserved history
1 daily buildsFiling coverage
5/6 membersproduct pipeline / R&D affecting expense
“Cash Flows Used in Operating Activities Net cash used in operating activities of $145.5 million and $131.6 million in the three months ended March 31, 2026 and 2025, respectively, was largely due to ongoing research and development activities and general and administrative expenses to support research and development as well as commercial readiness.”
CYTK 10-Q
credit / rates affecting interest expense
“Interest Expense, Net Interest expense, net increased $3.6 million during the three months ended March 31, 2026 compared to the prior year period primarily due to higher outstanding borrowings under our Revolving Credit Facility (as defined in “Liquidity and Capital Resources” below).”
BRBR 10-Q
credit / rates
“These drivers were partially offset by lower net borrowings of $20.0 million under our Revolving Credit Facility.”
BRBR 10-Q
Healthcare Nutrition & Biotech can stay leader-led if CYTK and the next software names fail to join while FMS keeps moving.
No high-confidence filing-linked non-members are available for this group yet.
Historical cohort observations are not available yet.